1. Home
  2. MIRM
  3. MIRM News

Latest Mirum Pharmaceuticals Inc. (MIRM) News on March 29, 2025

MIRM

MT Newswires

2 days ago

Mirum Pharmaceuticals Says Livmarli Approved in Japan for Pruritus

LIVMARLI Now Approved in Japan for ALGS and PFIC
MIRM

Business Wire

2 days ago

LIVMARLI Now Approved in Japan for ALGS and PFIC

Exploring 3 High Growth Tech Stocks in the US Market
MIRM

Simply Wall St.

5 days ago

Exploring 3 High Growth Tech Stocks in the US Market

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

19 days ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

24 days ago

Mirum Pharmaceuticals Insider Sold Shares Worth $676,928, According to a Recent SEC Filing

Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report
MIRM

Simply Wall St.

a month ago

Analyst Estimates: Here's What Brokers Think Of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) After Its Full-Year Report

Mirum Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations
MIRM

Simply Wall St.

a month ago

Mirum Pharmaceuticals Full Year 2024 Earnings: EPS Misses Expectations

MIRM

Thomson Reuters StreetEvents

a month ago

Q4 2024 Mirum Pharmaceuticals Inc Earnings Call

MIRM's Q4 Loss Wider Than Expected, Revenues Beat Estimates
MIRM

Zacks

a month ago

MIRM's Q4 Loss Wider Than Expected, Revenues Beat Estimates

MIRM

GuruFocus.com

a month ago

Mirum Pharmaceuticals Inc (MIRM) Q4 2024 Earnings Call Highlights: Record Sales Surge and ...

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates
MIRM

Zacks

a month ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q4 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
MIRM

Business Wire

a month ago

Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts
MIRM

Insider Monkey

a month ago

Mirum Pharmaceuticals (MIRM): Among the Best Performing Mid Cap Stocks to Buy According to Analysts

Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know
MIRM

Zacks

a month ago

Wall Street Analysts Predict a 26.18% Upside in Mirum Pharmaceuticals (MIRM): Here's What You Should Know

MIRM

MT Newswires

a month ago

Mirum Pharmaceuticals Says US FDA Approves Cerebrotendinous Xanthomatosis' Treatment Drug

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
MIRM

Business Wire

a month ago

Mirum’s CTEXLI™ (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)

Mirum drug for rare genetic disease gains FDA approval
MIRM

BioPharma Dive

a month ago

Mirum drug for rare genetic disease gains FDA approval

MIRM

MT Newswires

a month ago

Mirum Pharmaceuticals' Lipid Storage Disease Treatment Gets FDA Approval

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
MIRM

Business Wire

a month ago

Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025

High Growth Tech Stocks in United States to Watch
MIRM

Simply Wall St.

a month ago

High Growth Tech Stocks in United States to Watch

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

2 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

2 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $327,658, According to a Recent SEC Filing

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?
MIRM

Zacks

2 months ago

Mirum Pharmaceuticals (MIRM) Upgraded to Buy: What Does It Mean for the Stock?

MIRM

MT Newswires

2 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $319,598, According to a Recent SEC Filing

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results
MIRM

Zacks

2 months ago

MIRM Shares Rise 12% in a Week on Robust Preliminary 2024 Results

Exploring Three High Growth Tech Stocks in the United States
MIRM

Simply Wall St.

2 months ago

Exploring Three High Growth Tech Stocks in the United States

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?
MIRM

Zacks

2 months ago

Axsome (AXSM) Moves 11.5% Higher: Will This Strength Last?

Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why
MIRM

Zacks

2 months ago

Mirum Pharmaceuticals (MIRM) Is a Great Choice for 'Trend' Investors, Here's Why

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

3 months ago

Mirum Pharmaceuticals Insider Sold Shares Worth $320,644, According to a Recent SEC Filing

Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
MIRM

Business Wire

3 months ago

Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability
MIRM

Simply Wall St.

3 months ago

Mirum Pharmaceuticals, Inc.'s (NASDAQ:MIRM) Path To Profitability

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?
MIRM

Zacks

4 months ago

Why Is Mirum Pharmaceuticals (MIRM) Down 0.7% Since Last Earnings Report?

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

4 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities
MIRM

TipRanks

4 months ago

Mirum Pharmaceuticals price target raised to $74 from $69 at JMP Securities

Mirum Shares Surge More Than 90% in 6 Months: Here's Why
MIRM

Zacks

4 months ago

Mirum Shares Surge More Than 90% in 6 Months: Here's Why

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results
MIRM

Simply Wall St.

4 months ago

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting
MIRM

Business Wire

4 months ago

Mirum Pharmaceuticals to Showcase Data from its LIVMARLI and Volixibat Clinical Programs at AASLD’s The Liver Meeting

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations
MIRM

Simply Wall St.

4 months ago

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

MIRM

GuruFocus.com

5 months ago

Mirum Pharmaceuticals Inc (MIRM) Q3 2024 Earnings Call Highlights: Record Sales Surge and ...

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised
MIRM

Zacks

5 months ago

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates
MIRM

Zacks

5 months ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates

MIRM

MT Newswires

5 months ago

Mirum Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals Reports Third Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

High Growth Tech Stocks In The United States To Watch
MIRM

Simply Wall St.

5 months ago

High Growth Tech Stocks In The United States To Watch

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals to Announce Third Quarter 2024 Financial Results and Host Conference Call on November 12, 2024

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know
MIRM

Zacks

5 months ago

Will Mirum Pharmaceuticals, Inc. (MIRM) Report Negative Q3 Earnings? What You Should Know

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting
MIRM

Business Wire

5 months ago

Mirum Pharmaceuticals to Showcase LIVMARLI Data from its ALGS and PFIC Programs at the NASPGHAN Annual Meeting

Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales Growth
MIRM

Insider Monkey

5 months ago

Mirum Pharmaceuticals (MIRM): A Small-Cap Biotech with Strong Sales Growth

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

6 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

MIRM

MT Newswires

6 months ago

Mirum Pharmaceuticals Says Volixibat Gets FDA Breakthrough Therapy Designation in Cholestatic Pruritus

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis
MIRM

Business Wire

6 months ago

Volixibat Granted Breakthrough Therapy Designation for Cholestatic Pruritus in Primary Biliary Cholangitis

MIRM

GuruFocus.com

6 months ago

Mirum Pharmaceuticals Inc (MIRM) Q2 2024 Earnings Call Highlights: Record Sales Surge and ...

Exploring High Growth Tech Stocks In The US October 2024
MIRM

Simply Wall St.

6 months ago

Exploring High Growth Tech Stocks In The US October 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up
MIRM

Investor's Business Daily

7 months ago

Four Biotech Stocks Rally Toward Buy Points As Funds Load Up

Mirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?
MIRM

Zacks

7 months ago

Mirum Pharmaceuticals (MIRM) Up 4.5% Since Last Earnings Report: Can It Continue?

High Growth Tech Stocks To Watch In August 2024
MIRM

Simply Wall St.

7 months ago

High Growth Tech Stocks To Watch In August 2024

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
MIRM

Business Wire

7 months ago

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences

MIRM

MT Newswires

7 months ago

Evercore ISI Raises Price Target on Mirum Pharmaceuticals to $66 From $62, Keeps Outperform Rating

Mirum (MIRM) Banks on Livmarli, Overdependence a Concern
MIRM

Zacks

7 months ago

Mirum (MIRM) Banks on Livmarli, Overdependence a Concern

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates
MIRM

Simply Wall St.

8 months ago

Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

8 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum's (MIRM) Q2 Earnings Lag Estimates, Revenues Top
MIRM

Zacks

8 months ago

Mirum's (MIRM) Q2 Earnings Lag Estimates, Revenues Top

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates
MIRM

Zacks

8 months ago

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Tops Revenue Estimates

Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
MIRM

Business Wire

8 months ago

Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update

Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
MIRM

Business Wire

8 months ago

Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024

Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?
MIRM

Zacks

8 months ago

Mirum Pharmaceuticals (MIRM) Surges 7.3%: Is This an Indication of Further Gains?

MIRM

MT Newswires

8 months ago

Mirum Pharmaceuticals Gets FDA Label Expansion Approval for Liver Disease Treatment; Shares Jump

Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
MIRM

Business Wire

8 months ago

Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older

Mirum Pharmaceuticals (NASDAQ:MIRM) delivers shareholders solid 23% CAGR over 5 years, surging 11% in the last week alone
MIRM

Simply Wall St.

9 months ago

Mirum Pharmaceuticals (NASDAQ:MIRM) delivers shareholders solid 23% CAGR over 5 years, surging 11% in the last week alone

Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves
MIRM

Investor's Business Daily

9 months ago

Health Care Stocks Give IBD 50 A Boost, And These Are Making Bullish Moves

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
MIRM

Business Wire

9 months ago

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion
MIRM

Zacks

9 months ago

Mirum (MIRM) Gets EC Approval for Livmarli Label Expansion

Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why
MIRM

Zacks

9 months ago

Mirum (MIRM) Rises More Than 30% in Past 3 Months: Here's Why

MIRM

MT Newswires

9 months ago

Mirum Pharmaceuticals Gets Marketing Approval for Livmarli in Europe

Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC
MIRM

Business Wire

9 months ago

Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC

MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50
MIRM

Investor's Business Daily

9 months ago

MercadoLibre, A Few Other Growth Stocks, Among New Faces In IBD 50

MIRM

MT Newswires

9 months ago

Mirum Pharmaceuticals Submits New Drug Application for Cholesterol Metabolism Treatment

Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX
MIRM

Business Wire

9 months ago

Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX

Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling
MIRM

Investor's Business Daily

9 months ago

Biotech Stock Explodes On Drug Trial News As Sales Keep Doubling

MIRM

MT Newswires

9 months ago

Stifel Adjusts Mirum Pharmaceuticals Price Target to $66 From $48, Maintains Buy Rating

Mirum (MIRM) Soars on Interim Data From Liver Disease Studies
MIRM

Zacks

9 months ago

Mirum (MIRM) Soars on Interim Data From Liver Disease Studies

MIRM

MT Newswires

9 months ago

Evercore ISI Adjusts Price Target on Mirum Pharmaceuticals to $62 From $53, Maintains Outperform Rating

MIRM

MT Newswires

9 months ago

Raymond James Adjusts Price Target on Mirum Pharmaceuticals to $71 From $60, Maintains Strong Buy Rating

MIRM

MT Newswires

9 months ago

Citigroup Adjusts Price Target on Mirum Pharmaceuticals to $64 From $38, Maintains Buy Rating

MIRM

MT Newswires

9 months ago

JMP Securities Adjusts Price Target on Mirum Pharmaceuticals to $68 From $66, Maintains Market Outperform Rating

MIRM

MT Newswires

9 months ago

Morgan Stanley Adjusts Price Target on Mirum Pharmaceuticals to $57 From $53, Maintains Overweight Rating

MIRM

MT Newswires

9 months ago

JPMorgan Adjusts Price Target on Mirum Pharmaceuticals to $39 From $31, Maintains Overweight Rating

Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?
MIRM

Zacks

9 months ago

Mirum Pharmaceuticals (MIRM) Soars 27.3%: Is Further Upside Left in the Stock?

MIRM

MT Newswires

9 months ago

Sector Update: Health Care Stocks Retreat Late Afternoon

MIRM

MT Newswires

9 months ago

Sector Update: Health Care Stocks Ease in Afternoon Trading

MIRM

MT Newswires

9 months ago

Mirum Pharmaceuticals Advances after Reporting Positive Trial Results for Prospective Cholangitis Treatment

MIRM

MT Newswires

9 months ago

Cantor Fitzgerald Adjusts Price Target on Mirum Pharmaceuticals to $50 From $45, Maintains Overweight Rating

MIRM

MT Newswires

9 months ago

Baird Adjusts Mirum Pharmaceuticals Price Target to $39 From $34, Maintains Outperform Rating

Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies
MIRM

Business Wire

9 months ago

Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies

Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024
MIRM

Business Wire

9 months ago

Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024

Share on Social Networks: